CAS: 2649467-58-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Suzetrigine-13C-d3 REF: 4Z-S-259002CAS: 2649467-58-1 | - - - | To inquire | Wed 19 Feb 25 |
| Suzetrigine REF: 4Z-S-259001CAS: 2649467-58-1 | - - - | To inquire | Wed 19 Feb 25 |
 | Suzetrigine REF: TM-T69552CAS: 2649467-58-1 | 98.08% - 99.27% | 444.00 €~2,952.00 € | Wed 14 May 25 |
Ref: 4Z-S-259002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Ref: 4Z-S-259001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
Suzetrigine
CAS:2649467-58-1
Suzetrigine (VX-548) is an oral NaV1.8 inhibitor with analgesic properties for acute pain research.
Formula:
C21H20F5N3O4
Purity:
98.08% - 99.27%
Color and Shape:
Liquid
Molecular weight:
473.39
Ref: TM-T69552
| 1mg | 444.00 € | ||
| 5mg | 1,096.00 € | ||
| 10mg | 1,466.00 € | ||
| 25mg | 2,191.00 € | ||
| 50mg | 2,952.00 € |
Estimated delivery in United States, on Wednesday 14 May 2025
